Serum IL-1β, IL-6, IL-8, and TNF-α Levels in Early Diagnosis and Management of Neonatal Sepsis
2007

Serum Levels of Inflammatory Markers in Neonatal Sepsis

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): Kurt A. Nese Citak, Aygun A. Denizmen, Godekmerdan Ahmet, Kurt Abdullah, Dogan Yasar, Yilmaz Erdal

Primary Institution: Firat University

Hypothesis

To determine serum IL-1β, IL-6, IL-8, and TNF-α levels in neonatal sepsis at the time of diagnosis and after therapy.

Conclusion

Serum IL-1β, IL-6, IL-8, and TNF-α are mediators of inflammation and can be used at the diagnosis and at the evaluation of the therapeutic efficiency in neonatal sepsis.

Supporting Evidence

  • Serum levels of IL-1β, IL-6, IL-8, and TNF-α were significantly higher in culture-proven sepsis compared to controls.
  • Cytokine levels decreased significantly after seven days of antibiotic treatment.
  • The study included a total of 50 newborns with varying classifications of sepsis.

Takeaway

Doctors can check certain substances in the blood to help find out if a newborn has a serious infection called sepsis.

Methodology

This prospective study included newborns hospitalized for neonatal sepsis, classified into culture-proven sepsis, culture-negative sepsis, and healthy controls, with blood samples taken at diagnosis and after therapy.

Limitations

The study may have limitations related to sample size and the specificity of the cytokine measurements.

Participant Demographics

The study included 50 newborns: 12 with culture-proven sepsis, 21 with culture-negative sepsis, and 17 healthy controls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2007/31397

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication